Clinical Trial

Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 2

Completed
View on ClinicalTrials.gov →
Summary
This study is stage 2, round 2 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
Protocol Amendment History 2 changes
critical Completed without a posted recruiting period 2026-08-04
notable Enrollment increased: 300 -> 379 participants 2026-08-04
Trial Details
NCT Number NCT07602218
Lead Sponsor Yale University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Opioid Use Disorder, Clinical Decision Support
Enrollment 379 participants
Start Date 2026-05-26
Primary Completion 2026-07-13 (estimated)
Study Completion 2026-07-13 (estimated)
Updated on ClinicalTrials.gov 2026-08-03